论文部分内容阅读
临床诊断和治疗前列腺癌４０例，就诊时多为中晚期。３０例测定血清前列腺酸性磷酸酶（ＰＡＰ），２８例测定前列腺特异性抗原（ＰＳＡ），阳性率分别为５７％和８２１％，１９例病人作前列腺癌经直肠前壁穿刺抽吸活检细胞学检查。ＰＡＰ和ＰＳＡ对判断肿瘤分期、监测病情的发展和疗效有较大的临床价值，前列腺癌的细胞学检查，对前列腺癌的诊断，特别是早期前列腺癌的诊断及分级判断预后有重要的价值。随访４０例经内分泌治疗、双侧睾丸切除术、雌激素治疗等，疗效均在７０％以上，对５例早期前列腺癌作手术切除前列腺疗效较好。前列腺癌的死因主要是癌肿早期转移、梗阻性肾病。
Clinical diagnosis and treatment of prostate cancer in 40 cases, mostly in the late treatment. 30 cases of serum prostatic acid phosphatase (PAP), 28 cases of prostate specific antigen (PSA), the positive rates were 57% and 82 1%, 19 patients with prostate cancer transrectal anterior wall aspiration biopsy cells School inspection. PAP and PSA have great clinical value in judging tumor staging and monitoring the development and curative effect of disease. Cytological examination of prostate cancer has important value in the diagnosis of prostate cancer, especially in the diagnosis and classification of early stage prostate cancer. Follow-up of 40 cases of endocrine therapy, bilateral orchiectomy, estrogen therapy, the efficacy was more than 70%, 5 cases of early prostate cancer surgery for prostatectomy better. The main cause of prostate cancer is the early metastasis of cancer, obstructive nephropathy.